Cargando…
Von Willebrand factor and ADAMTS13 activity as clinical severity markers in patients with COVID-19
The coronavirus disease 2019 (COVID-19) increases thrombotic risk. The mechanisms that lead to this prothrombotic state are not well established. The main aim was to evaluate the von Willebrand factor (VWF) antigen and plasma ADAMTS13 activity as endothelial injury markers in COVID-19. We present a...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053027/ https://www.ncbi.nlm.nih.gov/pubmed/33866481 http://dx.doi.org/10.1007/s11239-021-02457-9 |